Amyloid-β-related genes SORL1 and ACE are genetically associated with risk for late-onset Alzheimer disease in the Chinese population

Alzheimer Disease and Associated Disorders

Volumn 24, Issue 4, 2010, Pages 390-396

  Ning, Mei ^a   Yang, Yifeng ^a   Zhang, Zhou ^a   Chen, Zhuo ^a   Zhao, Teng ^a   Zhang, Di ^a   Zhou, Daizhan ^a   Xu, Jie ^a   Liu, Zhe ^a   Wang, Yabing ^a   Liu, Yun ^a,b   Zhao, Xinzhi ^b   Li, Weidong ^c   Li, Sheng ^a   He, Lin ^a,b,c  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

ACE; Asian; Chinese; Haplotype; Late onset Alzheimer's disease; SORL1

Indexed keywords

AMYLOID BETA PROTEIN; ACE PROTEIN, HUMAN; CARRIER PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; SORL1 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; ASIAN; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LATE ONSET ALZHEIMER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; ONSET AGE; RISK FACTOR;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 78651403406     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3181e6a575     Document Type: Article

References (39)

1. Peacock ML, Fink JK. ApoE epsilon 4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology. 1994;44:339-341.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472. (Pubitemid 23230526)
3. Li H, Wetten S, Li L, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives Neurol. 2008;65:45-53.
4. Grupe A, Abraham R, Li Y, et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Human Molecular Genetics. 2007;16:865-873.
5. Coon KD, Myers AJ, Craig DW, et al. A high-density wholegenome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clinical Psychiat. 2007;68:613-618.
6. Bertram L, Tanzi RE. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nature Reviews Neuroscience. 2008;9:768-778.
7. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein-e to synthetic amyloid-beta peptideisoform-specific effects and implications for late-onset Alzheimer-disease. Proc Nat Acad Sci USA. 1993;90:8098-8102.
8. Daw EW, Payami H, Nemens EJ, et al. The number of trait loci in late-onset Alzheimer disease. Am J Human Gene. 2000;66:196-204.
9. Xu B-g, Wu X. Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004;26:201-209.
10. Probst A, Botez G, Tolnay M. Neuropathological aspects of Alzheimer disease. Ther Umsch. 1999;56:88-93.
11. Selkoe DJ. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behavioural Brain Res. 2008;192:106-113.
12. Takeda S, Sato N, Ogihara T, et al. The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential. Front Biosci. 2008;13:2253-2265.
13. Hu JG, Igarashi A, Kamata M, et al. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); Retards A beta aggregation, deposition, fibril formation, and inhibits cytotoxicity. J Biol Chem. 2001;276:47863-47868.
14. Cam JA, Bu GJ. Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family. Molecular Neurodegeneration. 2006;1:8.
15. Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilinrelated receptor SORL1 is genetically associated with Alzheimer disease. Nature Genetics. 2007;39:168-177.
16. Kehoe PG, Katzov H, Feuk L, et al. Haplotypes extending across ACE are associated with Alzheimer's disease. Human Molecular Genetics. 2003;12:859-867.
17. Meng Y, Baldwin CT, Bowirrat A, et al. Association of Polymorphisms in the angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community. Am J Hum Genetics. 2006;78:871-877.
18. Bruandet A, Richard F, Tzourio C, et al. Hanplotypes across ACE and the risk of Alzheimer's disease: the Three-City Study. J Alzheimers Dis. 2008;13:333-339.
19. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (Dipeptidyl Carboxypeptidase-1). Nucleic Acids Res. 1992;20:1433-1433.
20. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97-98.
21. Everitt BS, Hothorn T. A Handbook of Statistical Analyses Using R. Boston, MA: Chapman & Hall/CRC; 2006.
22. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149-150.
23. Li ZQ, Zhang Z, He ZD, et al. A partition-ligationcombination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Research. 2009;19:519-523.
24. Shibata N, Ohnuma T, Baba H, et al. Genetic association between SORL1 polymorphisms and Alzheimer's disease in a Japanese population. Dementia Geriatric Cognitive Disorders. 2008;26:161-164.
25. Kimura R, Yamamoto M, Morihara T, et al. SORL1 is genetically associated with Alzheimer disease in a Japanese population. Neurosci Lett. 2009;461:177-180.
26. Tan EK, Lee J, Chen CP, et al. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese. Neurobiol Aging. 2009;30:1048-1051.
27. Julian PT, Higgins SG. Cochrane Handbook for Systematic Reviews of Interventions 4.2. The Cochrane Library: The Cochrane Collaboration; 2003.
28. Bettens K, Brouwers N, Engelborghs S, et al. SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Human Mutation. 2008;29:769-770.
29. Li Y, Rowland C, Catanese J, et al. SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiol Disease. 2008;29:293-296.
30. Lee JH, Cheng R, Schupf N, et al. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Archives Neurol. 2007;64:501-506.
31. Kolsch H, Jessen F, Freymann N, et al. ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia. Neuroscience Letters. 2005;377:37-39.
32. Keikhaee MR, Hashemi SB, Najmabadi H, et al. C677T methylentetrahydrofulate reductase and Angiotensin Converting Enzyme gene polymorphisms in patients with Alzheimer's disease in Iranian population. Neurochemical Res. 2006;31:1079-1083.
33. Wang BB, Jin F, Yang Z, et al. The insertion polymorphism in Angiotensin-Converting Enzyme gene associated with the APOE epsilon 4 allele increases the risk of late-onset Alzheimer disease. J Molecular Neurosc. 2006;30:267-271.
34. Trebunova M, Slaba E, Habalova V, et al. ACE I/D polymorphism in Alzheimer's disease. Central Euro J Biol. 2008;3:49-54.
35. Elkins JS, Douglas VC, Johnston SC. Alzheimer disease risk and genetic variation in ACE-A meta-analysis. Neurol. 2004;62:363-368.
36. Narain Y, Yip A, Murphy T, et al. The ACE gene and Alzheimer's disease susceptibility. J Med Genet. 2000;37:695-697.
37. Kehoe PG, Katzov H, Andreasen N, et al. Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease. Human Genet. 2004;114:478-483.
38. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002;296:2225-2229.
39. Costerousse O, Allegrini J, Lopez M, et al. Angiotensin-I-converting enzyme in human circulating mononuclearcells-genetic-polymorphism of expression in lymphocytes-T. Biochemical J. 1993;290:33-40.